Identification of gene co-expression clusters in liver tissues from multiple porcine populations with high and low backfat androstenone phenotype

BMC Genetics

Volumn 16, Issue 1, 2015, Pages

  Sahadevan, Sudeep ^a,b   Tholen, Ernst ^a   Große Brinkhaus, Christine ^a   Schellander, Karl ^a   Tesfaye, Dawit ^a   Hofmann Apitius, Martin ^b   Cinar, Mehmet Ulas ^c   Gunawan, Asep ^d   Hölker, Michael ^a   Neuhoff, Christiane ^a  

^a UNIVERSITY OF BONN   (Germany)

^b FRAUNHOFER INSTITUTE FOR ALGORITHMS AND SCIENTIFIC COMPUTING SCAI   (Germany)

^c ERCIYES UNIVERSITY   (Turkey)

^d BOGOR AGRICULTURAL UNIVERSITY   (Indonesia)

Author keywords

Androgen metabolism; Androstenone; Boar taint; Cluster analysis; Co expression; Lipid metabolism; Microarray; Multiple dataset; RNA seq

Indexed keywords

ANDROSTENONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE CLUSTER; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC SIMILARITY; HIGH THROUGHPUT SCREENING; HORMONE DETERMINATION; HORMONE METABOLISM; LIVER; NONHUMAN; PHENOTYPE; PIG; ADIPOSE TISSUE; ANIMAL; BIOLOGY; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; INFORMATION PROCESSING; METABOLISM;

ADIPOSE TISSUE; ANIMALS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATASETS AS TOPIC; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; LIVER; SWINE;

EID: 84928264706     PISSN: None     EISSN: 14712156     Source Type: Journal    
DOI: 10.1186/s12863-014-0158-8     Document Type: Article

References (98)

1. Bonneau M. Compounds responsible for boar taint, with special emphasis on androstenone: A review. Livestock Production Sci. 1982;9(6): 687-705. doi:10.1016/0301-6226(82)90017-3.
2. Bonneau M, Le Denmat M, Vaudelet JC, Veloso Nunes JR, Mortensen AB, Mortensen HP. Contributions of fat androstenone and skatole to boar taint: I. Sensory attributes of fat and pork meat. Livestock Production Sci. 1992;32(1):63-80. doi:10.1016/S0301-6226(12)80012-1.
3. Frieden L, Looft C, Tholen E. Breeding for reduced boar taint. Lohmann Inf. 2011;46(1):21-7.
4. Sellier P, Roy PL, Fouilloux MN, Gruand J, Bonneau M. Responses to restricted index selection and genetic parameters for fat androstenone level and sexual maturity status of young boars. Livestock Production Sci. 2000;63(3):265-74. doi:10.1016/S0301-6226(99)00127-X.
5. Tajet H, Andresen O, Meuwissen THE. Estimation of genetic parameters of boar taint skatole and androstenone and their correlations with sexual maturation. Acta Veterinaria Scandinavica. 2006;48(Suppl 1):9. doi:10.1186/1751-0147-48-S1-S9.
6. Robic A, Larzul C, Bonneau M. Genetic and metabolic aspects of androstenone and skatole deposition in pig adipose tissue. A review. Genet Sel Evol. 2008;40(1):129. doi:10.1186/1297-9686-40-1-129.
7. Haugen J-E, Brunius C, Zamaratskaia G. Review of analytical methods to measure boar taint compounds in porcine adipose tissue: the need for harmonised methods. Meat Sci. 2012;90(1):9-19. doi:10.1016/j.meatsci.2011.07.005.
8. Mörlein D, Grave A, Sharifi AR, Bücking M, Wicke M. Different scalding techniques do not affect boar taint. Meat Sci. 2012;91(4):435-40. doi:10.1016/j.meatsci.2012.02.028.
9. James Squires E. Metabolism of androstenone and skatole. In: Applied Animal Endocrinology. 2nd edn. Cambridge: Cambridge University Press; Chap. 1.2.
10. Gunawan A, Sahadevan S, Neuhoff C, Große-Brinkhaus C, Gad A, Frieden L, et al. RNA deep sequencing reveals novel candiyear genes and polymorphisms in boar testis and liver tissues with divergent androstenone levels. PLoS ONE. 2013;8(5):63259. doi:10.1371/journal.pone.0063259.
11. Moe M, Grindflek E, Doran O. Expression of 3beta-hydroxysteroid dehydrogenase, cytochrome P450-c17, and sulfotransferase 2B1 proteins in liver and testis of pigs of two breeds: relationship with adipose tissue androstenone concentration. J Animal Sci. 2007;85(11):2924-31. doi:10.2527/jas.2007-0283.
12. Boulliou-Robic A, Feve K, Larzul C, Billon Y, Van Son M, Liaubet L, et al. Expression levels of 25 genes in liver and testis located in a QTL region for androstenone on SSC7q1.2. Animal Genet. 2011;42(6):662-5. doi:10.1111/j.1365-2052.2011.02195.x.
13. Doran E, Whittington FM, Wood JD, McGivan JD. Characterisation of androstenone metabolism in pig liver microsomes. Chemico-Biol Interact. 2004;147(2):14114-9. doi:10.1016/j.cbi.2003.12.002.
14. Robic A, Fève K, Larzul C, Billon Y, van Son M, Liaubet L, et al. Expression levels of 25 genes in liver and testis located in a QTL region for androstenone on SSC7q1.2. Animal Genet. 2011;42(6):662-5.
15. Moe M, Lien S, Bendixen C, Hedegaard J, Hornshøj H, Berget I, et al. Gene expression profiles in liver of pigs with extreme high and low levels of androstenone. BMC Veterinary Res. 2008;4:29.
16. Cue R-A, Nicolau-Solano SI, McGivan JD, Wood JD, Doran O. Breed-associated variations in the sequence of the pig 3beta-hydroxysteroid dehydrogenase gene. J Animal Sci. 2007;85(3): 571-6. doi:10.2527/jas.2006-366.
17. Xu C, Li CY-T, Kong A-NT. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch Pharmacal Res. 2005;28(3): 249-68.
18. Schänzer W. Metabolism of anabolic androgenic steroids. Clin Chem. 1996;42(7):1001-20.
19. Xie W, Yeuh M-F, Radominska-Pandya A, Saini SPS, Negishi Y, Bottroff BS, et al. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Nat Acad Sci. 2003;100(7):4150-5. doi:10.1073/pnas.0438010100.
20. Handschin C, Meyer UA. Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev. 2003;55(4):649-73. doi:10.1124/pr.55.4.2.
21. Nicolau-Solano SI, McGivan JD, Whittington FM, Nieuwhof GJ, Wood JD, Doran O. Relationship between the expression of hepatic but not testicular 3beta-hydroxysteroid dehydrogenase with androstenone deposition in pig adipose tissue. J Animal Sci. 2006;84(10):2809-17. doi:10.2527/jas.2005-595.
22. Sinclair PA, Hancock S, Gilmore WJ, Squires EJ. Metabolism of the 16-androstene steroids in primary cultured porcine hepatocytes. J Steroid Biochem. 2005;96(1):79-87. doi:10.1016/j.jsbmb.2005.01.030.
23. Moe M, Meuwissen T, Lien S, Bendixen C, Wang X, Conley LN, et al. Gene expression profiles in testis of pigs with extreme high and low levels of androstenone. BMC Genomics. 2007;8(1):405.
24. Grindflek E, Berget I, Moe M, Oeth P, Lien S. r. Transcript profiling of candiyear genes in testis of pigs exhibiting large differences in androstenone levels. BMC Genet. 2010;11(1):4. doi:10.1186/1471-2156-11-4.
25. Babraham Bioinformatics-FastQC A Quality Control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/ projects/fastqc/ Accessed 17/06/13.
26. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25(9):1105-11. doi:10.1093/bioinformatics/btp120.
27. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26(6):841-2. doi:10.1093/bioinformatics/btq033.
28. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139-40. doi:10.1093/bioinformatics/btp616.
29. Law CW, Chen Y, Shi W, Smyth GK. Voom! Precision weights unlock linear model analysis tools for RNA-seq read counts. Technical report, Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research. Australia: Melbourne 2013.
30. Smyth GK. Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York: Springer; 2005. p. 397-420.
31. R Development Core Team RDC. R. A Language and Environment for Statistical Computing. Vienna, Austria: Technical report, R Foundation for Statistical Computing; 2013.
32. Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846-7. doi:10.1093/bioinformatics/btm254.
33. Archibald AL, Bolund L, Churcher C, Fredholm M, Groenen MAM, Harlizius B, et al. Pig genome sequence-analysis and publication strategy. BMC Genomics. 2010;11(1):438. doi:10.1186/1471-2164-11-438.
34. Mount DW. Using the Basic Local Alignment Search Tool (BLAST). CSH protocols. 2007;2007(7):17. doi:10.1101/pdb.top17.
35. Stuart JM, Segal E, Koller D, Kim SK. A gene-coexpression network for global discovery of conserved genetic modules. Science. 2003;302(5643): 249-55. doi:10.1126/science.1087447.
36. Rosvall M, Axelsson D, Bergstrom CT. The map equation. Eur Phys J Special Top. 2010;178(1):13-23. doi:10.1140/epjst/e2010-01179-1.
37. Lancichinetti A, Fortunato S. Community detection algorithms: A comparative analysis. Physical Review E. 2009;80(5):12. doi:10.1103/PhysRevE.80.056117.0908.1062.
38. Lancichinetti A, Radicchi F, Ramasco JJ, Fortunato S. Finding statistically significant communities in networks. PLoS ONE. 2011;6(4):18961. doi:10.1371/journal.pone.0018961.
39. Clauset A, Newman M, Moore C. Finding community structure in very large networks. Phys Rev E. 2004;70(6):066111. doi:10.1103/PhysRevE.70.066111.
40. Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. J Stat Mech: Theory Exp. 2008;2008(10):1008. doi:10.1088/1742-5468/2008/10/P10008.
41. Raghavan U, Albert R, Kumara S. Near linear time algorithm to detect community structures in large-scale networks. Phys Rev E. 2007;76(3):036106.doi:10.1103/PhysRevE.76.036106.
42. Lancichinetti A, Fortunato S. Consensus clustering in complex networks. Sci R. 2012;2:336. doi:10.1038/srep00336.
43. Goder A, Filkov V. Consensus Clustering Algorithms: Comparison and Refinement. In: Proc. 9th Workshop on Algorithm Engineering and Experiments (ALENEX'08). San Francisco, California, USA: SIAM; 2008. p. 109-17.
44. Topchy A, Jain AK, Punch W. Clustering ensembles: models of consensus and weak partitions. IEEE Trans Pattern Anal Machine Intelligence. 2005;27(12):1866-81. doi:10.1109/TPAMI.2005.237.
45. Strehl A, Ghosh J, Cardie C., Cluster Ensembles-A. Knowledge Reuse Framework for Combining Multiple Partitions. J Machine Learning Res. 2002;3:583-617.
46. Alexa A, Rahnenfuhrer J. topGO: Enrichment analysis for Gene Ontology: Technical report; 2010.
47. Alexa A, Rahnenführer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006;22(13):1600-7. doi:10.1093/bioinformatics/btl140.
48. Lord PW, Stevens RD, Brass A, Goble CA. Investigating semantic similarity measures across the Gene Ontology: the relationship between sequence and annotation. Bioinformatics. 2003;19(10):1275-83. doi:10.1093/bioinformatics/btg153.
49. Schlicker A, Domingues FS, Rahnenführer J, Lengauer T. A new measure for functional similarity of gene products based on Gene Ontology. BMC Bioinf. 2006;7:302. doi:10.1186/1471-2105-7-302.
50. Wang JZ, Du Z, Payattakool R, Yu PS, Chen C-F. A new method to measure the semantic similarity of GO terms. Bioinformatics. 2007;23(10): 1274-81. doi:10.1093/bioinformatics/btm087.
51. Resnik P. Semantic similarity in a taxonomy: An information-based measure and its application to problems of ambiguity in natural language. J Artif Intelligence Res. 1999;11:95-130.
52. Jiang JJ, Conrath DW. Semantic similarity based on corpus statistics and lexical taxonomy. In: Proceedings of the International Conference on Research in Computational Linguistics. Taipei: Computing Research Repository; 1997. p. 19-33.
53. Lin D. An Information-Theoretic Definition of Similarity. In: ICML. Madison. USA: Morgan Kaufmann; 1998. p. 296-304.
54. Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010;26(7):976-8. doi:10.1093/bioinformatics/btq064.
55. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498-504.
56. Gibson GG, Skett P, Introduction to Drug Metabolism, illustrate edn. Cheltenham, Great Britain: Nelson Thornes Publishers; 2001, p. 256.
57. Xie W. Nuclear Receptors in Drug Metabolism. New Jersey, USA: Wiley; 2008, p. 336.
58. de Montellano PRO. New York: Springer, p. 652.
59. Foye WO, Lemke TL, Williams DA. Foye's Principles of Medicinal Chemistry: Philadelphia: Lippincott Williams & Wilkins; 2008, p. 1377.
60. Jin Y, Penning TM. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Pract & Res Clin Endocrinology & Metab. 2001;15(1):79-94. doi:10.1053/beem.2001.0120.
61. Yoshida A, Rzhetsky A, Hsu LC, Chang C. Human aldehyde dehydrogenase gene family. Eur J Biochem/FEBS. 1998;251(3):549-57.
62. Vasiliou V, Nebert DW. Analysis and upyear of the human aldehyde dehydrogenase (ALDH) gene family. Human Genomics. 2005;2(2):138-43.
63. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S-i, Iyanagi T, et al. Nomenclature upyear for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenetics and Genomics. 2005;15(10): 677-85.
64. Coffman BL, King CD, Rios GR, Tephly TR. The Glucuronidation of Opioids, Other Xenobiotics, and Androgens by Human UGT2B7Y(268) and UGT2B7H(268). Drug Metab Dispos. 1998;26(1):73-7.
65. Ritter JK. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chemico-Biol Interact. 2000;129(1-2): 171-93. doi:10.1016/S0009-2797(00)00198-8.
66. Turgeon D. Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics. Drug Metab Dispos. 2003;31(5):670-6. doi:10.1124/dmd.31.5.670.
67. Jin Y, Duan L, Lee SH, Kloosterboer HJ, Blair IA, Penning TM. Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism. J Biol Chem. 2009;284(15):10013-22. doi:10.1074/jbc.M809465200.
68. Beaulieu M, Lévesque E, Barbier O, Turgeon D, Bélanger G, Hum DW, et al. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens. J Mol Biol. 1998;275(5):785-94. doi:10.1006/jmbi.1997.1486.
69. Kojima M, Degawa M. Sex Differences in the Constitutive Gene Expression of Sulfotransferases and UDP-glucuronosyltransferases in the Pig Liver: Androgen-Mediated Regulation. Drug Metab Pharmacokinetics [Epub]. 2014;29(2):192-7. http://www.ncbi.nlm.nih.gov/pubmed/24172717.
70. Soars MG, Fettes M, O'Sullivan AC, Riley RJ, Ethell BT, Burchell B. Cloning and characterisation of the first drug-metabolising canine UDP-glucuronosyltransferase of the 2B subfamily. Biochem Pharmacol. 2003;65(8):1251-9. doi:10.1016/S0006-2952(03)00064-9.
71. Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Investigative Dermatology. 2002;119(5):992-1007. doi:10.1046/j.1523-1747.2002.00613.x.
72. de Launoit Y, Adamski J. Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome. J Mol Endrocrinology. 1999;22(3):227-40.
73. Prough RA, Webb SJ, Wu HQ, Lapenson DP, Waxman DJ. Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Res. 1994;54(11):2878-86.
74. He XY, Merz G, Yang YZ, Mehta P, Schulz H, Yang SY. Characterization and localization of human type10 17beta-hydroxysteroid dehydrogenase. Eur J Biochem/FEBS. 2001;268(18):4899-907.
75. Skogsberg J, Lundström J, Kovacs A, Nilsson R, Noori P, Maleki S, et al. Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes. PLoS Genet. 2008;4(3):1000036. doi:10.1371/journal.pgen.1000036.
76. Emami Riedmaier A, Nies AT, Schaeffeler E, Schwab M. Organic anion transporters and their implications in pharmacotherapy. Pharmacol Rev. 2012;64(3):421-49. doi:10.1124/pr.111.004614.
77. Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA. Aldehyde dehydrogenases and cell proliferation. Free Radical Biol Med. 2012;52(4): 735-46. doi:10.1016/j.freeradbiomed.2011.11.033.
78. Zhang Y, Dufort I, Rheault P, Luu-The V. Characterization of a human 20alpha-hydroxysteroid dehydrogenase. J Mol Endrocrinology. 2000;25(2):221-28.
79. Steckelbroeck S, Jin Y, Gopishetty S, Oyesanmi B, Penning TM. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J Biol Chem. 2004;279(11):10784-95. doi:10.1074/jbc.M313308200.
80. Lou H, Du S, Ji Q, Stolz A. Induction of AKR1C2 by phase II inducers: identification of a distal consensus antioxidant response element regulated by NRF2. Mol Pharmacol. 2006;69(5):1662-72. doi:10.1124/mol.105.019794.
81. Brooks SA, Harris A. Breast Cancer Research Protocols. Biomed Protoc. New York: Humana Press; 2006, p. 517.
82. der Zee AHM, Daly AK. Pharmacogenetics and Individualized Therapy: Wiley; 2012, p. 432.
83. Riegelhaupt JJ, Waase MP, Garbarino J, Cruz DE, Breslow JL. Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism. J Lipid Res. 2010;51(5):1134-43. doi:10.1194/jlr.M003095.
84. Rodriguez-Agudo D, Ren S, Wong E, Marques D, Redford K, Gil G, et al. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J Lipid Res. 2008;49(7):1409-19. doi:10.1194/jlr.M700537-JLR200.
85. Rodriguez-Agudo D, Calderon-Dominguez M, Ren S, Marques D, Redford K, Medina-Torres MA, et al. Subcellular localization and regulation of StarD4 protein in macrophages and fibroblasts. Biochim et Biophysica Acta. 2011;1811(10):597-606. doi:10.1016/j.bbalip.2011.06.028.
86. Mesmin B, Pipalia NH, Lund FW, Ramlall TF, Sokolov A, Eliezer D, et al. STARD4 abundance regulates sterol transport and sensing. Mol Biol Cell. 2011;22(21):4004-15. doi:10.1091/mbc.E11-04-0372.
87. Plapp BV, Berst KB. Specificity of human alcohol dehydrogenase 1C*2 (gamma2gamma2) for steroids and simulation of the uncompetitive inhibition of ethanol metabolism. Chemico-biol Interact. 2003;143-144:183-93.
88. Lösel RM, Besong D, Peluso JJ, Wehling M. Progesterone receptor membrane component 1-many tasks for a versatile protein. Steroids. 2008;73(9-10):929-34. doi:10.1016/j.steroids.2007.12.017.
89. Venturini I, Zeneroli ML, Corsi L, Baraldi C, Ferrarese C, Pecora N, et al. Diazepam binding inhibitor and total cholesterol plasma levels in cirrhosis and hepatocellular carcinoma. Regul Peptides. 1998;74(1):31-4.
90. Rasmussen JT, Rosendal J, Knudsen J. Interaction of acyl-CoA binding protein (ACBP) on processes for which acyl-CoA is a substrate, product or inhibitor. Biochem J. 1993;292(Pt.3):907-13.
91. Taulan M, Paquet F, Maubert C, Delissen O, Demaille J, Romey M-C. Renal toxicogenomic response to chronic uranyl nitrate insult in mice. Environ Health Perspect. 2004;112(16):1628-35.
92. Stanley WA, Filipp FV, Kursula P, Schüller N, Erdmann R, Schliebs W, et al. Recognition of a functional peroxisome type 1 target by the dynamic import receptor Pex5p. Mol Cell. 2006;24(5):653-63. doi:10.1016/j.molcel.2006.10.024.
93. Fuchs M, Hafer A, Münch C, Kannenberg F, Teichmann S, Scheibner J, et al. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism. J Biol Chem. 2001;276(51): 48058-65. doi:10.1074/jbc.M106732200.
94. Garattini E, Fratelli M, Terao M. The mammalian aldehyde oxidase gene family. Human Genomics. 2009;4(2):119-30.
95. Müller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A, et al. FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 2000;19(3):359-69. doi:10.1093/emboj/19.3.359.
96. Heemers HV, Regan KM, Dehm SM, Tindall DJ. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer. Cancer Res. 2007;67(21):10592-9. doi:10.1158/0008-5472.CAN-07-1917.
97. Kleiber K, Strebhardt K, Martin BT. The biological relevance of FHL2 in tumour cells and its role as a putative cancer target. Anticancer Res. 2007;27(1A):55-61.
98. Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res. 2005;46(6): 1239-47. doi:10.1194/jlr.M400511-JLR200.